Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2010

01-12-2010 | Research Report

Social-adaptive and psychological functioning of patients affected by Fabry disease

Authors: Dawn Alyssia Laney, Daniel J. Gruskin, Paul M. Fernhoff, Joseph F. Cubells, Opal Y. Ousley, Heather Hipp, Ami J. Mehta

Published in: Journal of Inherited Metabolic Disease | Special Issue 3/2010

Login to get access

Summary

Fabry disease (FD) is an X-linked lysosomal storage disorder caused by the deficiency of alpha-galactosidase A. In addition to the debilitating physical symptoms of FD, there are also under-recognized and poorly characterized psychiatric features. As a first step toward characterizing psychiatric features of FD, we administered the Achenbach adult self report questionnaire to 30 FD patients and the Achenbach adult behavior checklist questionnaire to 28 partners/parents/friends of FD patients. Data from at least one of the questionnaires were available on 33 subjects. Analysis focused on social-adaptive functioning in various aspects of daily life and on criteria related to the Diagnostic and statistical manual of mental disorders IV (DSM-IV). Adaptive functioning scale values, which primarily measure social and relationship functioning and occupational success, showed that eight FD patients (six female and two male) had mean adaptive functioning deficits as compared to population norms. Greater rates of depression (P < 0.01), anxiety (P = 0.05), depression and anxiety (P = 0.03), antisocial personality (P < 0.001), attention-deficit/hyperactivity (AD/H; P < 0.01), hyperactivity–impulsivity (P < 0.01), and aggressive behavior (P = 0.03) were associated with poorer adaptive functioning. Decreased social-adaptive functioning in this study was not statistically significantly associated to disease severity, pain, or level of vitality. This study shows for the first time that FD patients, particularly women, are affected by decreased social-adaptive functioning. Comprehensive treatment plans for FD should consider assessments and interventions to evaluate and improve social, occupational, and psychological functioning. Attention to the behavioral aspects of FD could lead to improved treatment outcome and improved quality of life. Individuals affected by Fabry disease exhibited social-adaptive functioning deficits that were significantly correlated with anxiety, depression, antisocial behavior, and AD/H problems in a sampling of our male and female patients aged between 18 years and 59 years.
Literature
go back to reference Achenbach TM, Rescorla LA (2003) Manual for the ASEBA adult forms and profiles. University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT, www.aseba.org Achenbach TM, Rescorla LA (2003) Manual for the ASEBA adult forms and profiles. University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT, www.​aseba.​org
go back to reference Achenbach TM, Bernstein A, Dumenci L (2005) DSM-oriented scales and statistically based syndromes for ages 18 to 59: Linking taxonomic paradigms to facilitate multitaxonomic approaches. J Pers Assess 84:49–63PubMedCrossRef Achenbach TM, Bernstein A, Dumenci L (2005) DSM-oriented scales and statistically based syndromes for ages 18 to 59: Linking taxonomic paradigms to facilitate multitaxonomic approaches. J Pers Assess 84:49–63PubMedCrossRef
go back to reference Beck M (2006) The Mainz severity score index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95:43–46PubMedCrossRef Beck M (2006) The Mainz severity score index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95:43–46PubMedCrossRef
go back to reference Berenbaum SA, Bryk KK, Duck SC, Resnick SM (2004) Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 144:741–746PubMed Berenbaum SA, Bryk KK, Duck SC, Resnick SM (2004) Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 144:741–746PubMed
go back to reference Brady R, Grabowski GA, Thadhani R (2001) Fabry disease: Review and new perspective. SynerMed Communications 1:1–8 Brady R, Grabowski GA, Thadhani R (2001) Fabry disease: Review and new perspective. SynerMed Communications 1:1–8
go back to reference Buysse CM, Raat H, Hazelzet JA et al (2007) Long-term psychosocial outcomes in survivors of meningococcal septic shock in childhood, and in their parents. Qual Life Res 16:1567–1576PubMedCrossRef Buysse CM, Raat H, Hazelzet JA et al (2007) Long-term psychosocial outcomes in survivors of meningococcal septic shock in childhood, and in their parents. Qual Life Res 16:1567–1576PubMedCrossRef
go back to reference Carpenter RE, Loo SK, Yang M, Dang J, Smalley SL (2009) Social functioning difficulties in ADHD: association with PDD risk. Clin Child Psychol Psychiatry 14:329–344CrossRef Carpenter RE, Loo SK, Yang M, Dang J, Smalley SL (2009) Social functioning difficulties in ADHD: association with PDD risk. Clin Child Psychol Psychiatry 14:329–344CrossRef
go back to reference Cleeland CS (2002) Pain assessment: the advantages of using pain scales in lysosomal storage diseases. Acta Paediatr Suppl 91:43–47PubMedCrossRef Cleeland CS (2002) Pain assessment: the advantages of using pain scales in lysosomal storage diseases. Acta Paediatr Suppl 91:43–47PubMedCrossRef
go back to reference Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138PubMed Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138PubMed
go back to reference Cole A, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30:943–951PubMedCrossRef Cole A, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30:943–951PubMedCrossRef
go back to reference Compas BE, Boyer MC, Stanger C et al (2006) Latent variable analysis of coping, anxiety/depression, and somatic symptoms in adolescents with chronic pain. J Consult Clin Psychol 74:1132–1142PubMedCrossRef Compas BE, Boyer MC, Stanger C et al (2006) Latent variable analysis of coping, anxiety/depression, and somatic symptoms in adolescents with chronic pain. J Consult Clin Psychol 74:1132–1142PubMedCrossRef
go back to reference Cubells JF (2007) Beyond irritability and aggressive behavior: does risperidone improve adaptive behavior in autistic spectrum disorders? Curr Psychiatry Rep 9:132–133PubMed Cubells JF (2007) Beyond irritability and aggressive behavior: does risperidone improve adaptive behavior in autistic spectrum disorders? Curr Psychiatry Rep 9:132–133PubMed
go back to reference Desnick R, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346PubMedCrossRef Desnick R, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346PubMedCrossRef
go back to reference Gold K, Pastores GM, Botteman MF et al (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317–327PubMedCrossRef Gold K, Pastores GM, Botteman MF et al (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317–327PubMedCrossRef
go back to reference Gothelf D, Feinstein C, Thompson T et al (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164:663–669PubMedCrossRef Gothelf D, Feinstein C, Thompson T et al (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164:663–669PubMedCrossRef
go back to reference Gray D, Parker-Cohen NY, White T, Clark ST, Seiner SHAJ, McMahon WM (2001) A comparison of individual and family psychology of adolescents with chronic fatigue syndrome, rheumatoid arthritis, and mood disorders. J Dev Behav Pediatr 22:234–242PubMedCrossRef Gray D, Parker-Cohen NY, White T, Clark ST, Seiner SHAJ, McMahon WM (2001) A comparison of individual and family psychology of adolescents with chronic fatigue syndrome, rheumatoid arthritis, and mood disorders. J Dev Behav Pediatr 22:234–242PubMedCrossRef
go back to reference Grewal R (1993) Psychiatric disorders in patients with Fabry disease. Int J Psychiatry Med 23:308–312CrossRef Grewal R (1993) Psychiatric disorders in patients with Fabry disease. Int J Psychiatry Med 23:308–312CrossRef
go back to reference Hack M, Youngstrom EA, Cartar L et al (2004) Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 114:932–940PubMedCrossRef Hack M, Youngstrom EA, Cartar L et al (2004) Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 114:932–940PubMedCrossRef
go back to reference Hinton VJ, Nereo NE, Fee RJ, Cyrulnik SE (2006) Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr 27:470–476PubMedCrossRef Hinton VJ, Nereo NE, Fee RJ, Cyrulnik SE (2006) Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr 27:470–476PubMedCrossRef
go back to reference Hoffman B, Garcia de Lorenzo A, Mehta A et al (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet 42:247–252CrossRef Hoffman B, Garcia de Lorenzo A, Mehta A et al (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet 42:247–252CrossRef
go back to reference Hoffman B, Beck M, Sunder Plassman G et al (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy—a retrospective analysis from the Fabry outcome survey. Clin J Pain 23:535–542CrossRef Hoffman B, Beck M, Sunder Plassman G et al (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy—a retrospective analysis from the Fabry outcome survey. Clin J Pain 23:535–542CrossRef
go back to reference Howe GW, Feinstein C, Reiss D, Molock S, Berger K (1993) Adolescent adjustment to chronic physical disorders: I. Comparing neurological and non-neurological conditions. J Child Psychol Psychiatry 34:1153–1171PubMedCrossRef Howe GW, Feinstein C, Reiss D, Molock S, Berger K (1993) Adolescent adjustment to chronic physical disorders: I. Comparing neurological and non-neurological conditions. J Child Psychol Psychiatry 34:1153–1171PubMedCrossRef
go back to reference Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ (2002) The heart in Anderson Fabry disease. Z Kardiol 91:786–795PubMedCrossRef Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ (2002) The heart in Anderson Fabry disease. Z Kardiol 91:786–795PubMedCrossRef
go back to reference Katon W, Russo J, Lin EH et al (2009) Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 50:570–579 Katon W, Russo J, Lin EH et al (2009) Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 50:570–579
go back to reference Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont) 6:38–51 Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont) 6:38–51
go back to reference MacDermot K, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769–775PubMedCrossRef MacDermot K, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769–775PubMedCrossRef
go back to reference Miners A, Holmes A, Sherr L et al (2002) Assessment of health-related quality-of-life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127–133PubMedCrossRef Miners A, Holmes A, Sherr L et al (2002) Assessment of health-related quality-of-life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127–133PubMedCrossRef
go back to reference Muller M, Muller KM, Dascalescu A et al (2005) Psychiatric and neuropsychological signs and symptoms in patients with Fabry disease: literature review. Fortschr Neurol Psychiatr 73:687–693PubMedCrossRef Muller M, Muller KM, Dascalescu A et al (2005) Psychiatric and neuropsychological signs and symptoms in patients with Fabry disease: literature review. Fortschr Neurol Psychiatr 73:687–693PubMedCrossRef
go back to reference Mureau MAM, Slijper FME, Slob AK, Verhulst FC (1997) Psychosocial functioning of children, adolescents, and adults following hypospadias surgery: a comparative study. J Pediatr Psychol 22:371–387PubMedCrossRef Mureau MAM, Slijper FME, Slob AK, Verhulst FC (1997) Psychosocial functioning of children, adolescents, and adults following hypospadias surgery: a comparative study. J Pediatr Psychol 22:371–387PubMedCrossRef
go back to reference RADAR (2009) The Fabry Registry Aggregate Data Annual Report (RADAR). Fabry registry. Genzyme Corporation, Boston, MA RADAR (2009) The Fabry Registry Aggregate Data Annual Report (RADAR). Fabry registry. Genzyme Corporation, Boston, MA
go back to reference Roza SJ, Hofstra MB, van der Ende J, Verhulst FC (2003) Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood. Am J Psychiatry 160:2116–2121PubMedCrossRef Roza SJ, Hofstra MB, van der Ende J, Verhulst FC (2003) Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood. Am J Psychiatry 160:2116–2121PubMedCrossRef
go back to reference Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201PubMedCrossRef Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201PubMedCrossRef
go back to reference Sbarra DA, Rimm-Kaufman SE, Pianta RC (2002) The behavioral and emotional correlates of epilepsy in adolescence: a 7-year follow-up. Epilepsy Behav 3:358–367PubMedCrossRef Sbarra DA, Rimm-Kaufman SE, Pianta RC (2002) The behavioral and emotional correlates of epilepsy in adolescence: a 7-year follow-up. Epilepsy Behav 3:358–367PubMedCrossRef
go back to reference Schiffmann R, Scott LJ (2002) Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl 91:48–52PubMedCrossRef Schiffmann R, Scott LJ (2002) Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl 91:48–52PubMedCrossRef
go back to reference Stavro GM, Ettenhofer ML, Nigg JT (2007) Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc 13:324–334PubMedCrossRef Stavro GM, Ettenhofer ML, Nigg JT (2007) Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc 13:324–334PubMedCrossRef
go back to reference Street N, Yi MS, Bailey LA, Hopkin RJ (2006) Comparison of health related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med 8:346–353PubMedCrossRef Street N, Yi MS, Bailey LA, Hopkin RJ (2006) Comparison of health related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med 8:346–353PubMedCrossRef
go back to reference Todd RD, Huang H, Todorov AA, Neuman RJ, Reiersen AM, Henderson CA, Reich WC (2008) Predictors of stability of attention-deficit/hyperactivity disorder subtypes from childhood to young adulthood. J Am Acad Child Adolesc Psychiatry 47:76–85PubMedCrossRef Todd RD, Huang H, Todorov AA, Neuman RJ, Reiersen AM, Henderson CA, Reich WC (2008) Predictors of stability of attention-deficit/hyperactivity disorder subtypes from childhood to young adulthood. J Am Acad Child Adolesc Psychiatry 47:76–85PubMedCrossRef
go back to reference van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2007) Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study. Psychol Med 37:1635–1644PubMed van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2007) Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study. Psychol Med 37:1635–1644PubMed
go back to reference van Pareren YK, Duivenvoorden HJ, Slijper FME et al (2005) Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm Res 63:238–244 van Pareren YK, Duivenvoorden HJ, Slijper FME et al (2005) Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm Res 63:238–244
go back to reference van Rijen EHM, Utens EMWJ, Roos-Hesselink JW et al (2004) Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 25:1605–1613PubMedCrossRef van Rijen EHM, Utens EMWJ, Roos-Hesselink JW et al (2004) Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 25:1605–1613PubMedCrossRef
go back to reference Väistö T, Aronen ET, Simola P, Ashorn M, Kolho KL (2009) Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis 16:27–35 Väistö T, Aronen ET, Simola P, Ashorn M, Kolho KL (2009) Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis 16:27–35
go back to reference Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34–45 Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34–45
go back to reference West M, LeMoine K (2007) Withdrawal of enzyme replacement therapy in Fabry disease: indirect evidence of treatment benefit? Mol Genet Metab 92:32CrossRef West M, LeMoine K (2007) Withdrawal of enzyme replacement therapy in Fabry disease: indirect evidence of treatment benefit? Mol Genet Metab 92:32CrossRef
go back to reference Whybra C, Kampmann C, Krummenauer F et al (2004) The Mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299–307PubMedCrossRef Whybra C, Kampmann C, Krummenauer F et al (2004) The Mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299–307PubMedCrossRef
go back to reference Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112–128PubMedCrossRef Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112–128PubMedCrossRef
Metadata
Title
Social-adaptive and psychological functioning of patients affected by Fabry disease
Authors
Dawn Alyssia Laney
Daniel J. Gruskin
Paul M. Fernhoff
Joseph F. Cubells
Opal Y. Ousley
Heather Hipp
Ami J. Mehta
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 3/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-9025-6

Other articles of this Special Issue 3/2010

Journal of Inherited Metabolic Disease 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.